SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy
SANG 5.180+2.4%Dec 19 10:55 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John S. Sturges who wrote (90)2/21/1998 12:16:00 PM
From: deadstrait  Read Replies (1) of 184
 
On Feb 13, 1998, H&Q reiterated their strong buy rating on SANG with
a 12 month target of $60.

Also, same day, Nationsbanc Montgomery reiterated it's "buy" rating
with a target price of $40.

I'd love to see $60 but would be very happy with $40.

IMHO--With SANG looking to be profitable by by the end of the year, I
am comfortable somewhere in between.

Dead
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News